SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Neurocrine Biosciences (NBIX)
An SI Board Since July 1996
Posts SubjectMarks Bans Symbol
1834 74 0 NBIX
Emcee:  Billy Dunn Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
110910 min does not sound like huge difference. Without WASO and TST (regardless thaMiljenko Zuanic-4/21/2003
1108A small correction - only the first Estorra trial was PSG monitored. Not surprisBiomaven-4/21/2003
1107I know comparing across trials is fraught with danger, but there are hints that Biomaven-4/21/2003
1106Just to note--Scharf said the polysomnography data shows no rebound with Ambien NeuroInvestment-4/21/2003
1105A few additional notes: 1. ~71% pts respond 2. Subjective measures similarly keokalani'nui-4/21/2003
1104Neurocrine Biosciences Reports Positive Results From Second Phase III Clinical Tscaram(o)uche-4/21/2003
1103Today 1:30pdt. P3 Chronic Insomnia results. Neurocrine Biosciences Announces Wkeokalani'nui-4/21/2003
1102Neurocrine Biosciences Announces U.S. Issuance of Polymorph Composition and Methscaram(o)uche-4/11/2003
1101The Journal of Clinical Endocrinology & Metabolism Vol. 88, No. 4 1697-1704 Miljenko Zuanic-4/10/2003
1100NBIX Announces the Appointment of Lloyd E. Flanders, Ph.D. to the Position of Semopgcw-4/8/2003
1099A chunk of insider sales at the end of March roughly 250k shares worth.mopgcw-4/8/2003
1098Thanks. Another good review (GnRHr antagonists) is Lancet 2001; 358:1793-803. Bykeokalani'nui-3/18/2003
1097GnRH review: journals.endocrinology.orgMiljenko Zuanic-3/18/2003
1096I have been following Hypnion for about two years now, and like their screening NeuroInvestment-3/18/2003
1095Early to worry even if there's anything to worry about here, and the market RCMac-3/17/2003
1094Biosite(R) Announces Collaboration Agreement With Neurocrine Biosciences Thursdascaram(o)uche-2/20/2003
1093Hedge at NBIX: secfilings.nasdaq.com secfilings.nasdaq.com [eom]Miljenko Zuanic-2/18/2003
1092OT This is an amazing story, as it describes the molecular details of a receptorBiotech Jim-2/6/2003
1091Proc Natl Acad Sci U S A 2003 Feb 4;100(3):940-945 Links beta -Arrestin-mediakeokalani'nui-2/5/2003
1090Neurocrine Biosciences Reports Fourth Quarter 2002 Results; Company Provides Updmopgcw-2/3/2003
1089Morgan Stanley resumes coverage w/ an equal-weight and $55 target. fwiw.mopgcw-1/28/2003
1088Once again thanks to all for kind wishes. MiljenkoMiljenko Zuanic-1/26/2003
1087Congratulations, Miljenko! From my experience boys are easier to deal with than hmpa-1/24/2003
1086MZ, No higher calling hath a man than to be a parent. Congratulations and God BThe Dodgy Ticker-1/24/2003
1085Wonderful news. Spend lots of time with them. They need to learn from you. CheriMark Bong-1/24/2003
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News